Wednesday, July 16, 2025 7/16/2025

Determining the subcellular and molecular players in neutrophil trogocytic killing of the sexually-transmitted parasite Trichomonas vaginalis

Award Number: SC3GM135046
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/10/2020
PERIOD OF PERFORMANCE END DATE: 01/31/2025

Group Awards By:

View Award Description

Determining the subcellular and molecular players in neutrophil trogocytic killing of the sexually-transmitted parasite Trichomonas vaginalis - PROJECT SUMMARY Trichomonas vaginalis is a unicellular, motile protozoan parasite responsible for the 3rd- most common sexually-transmitted infection in the US and worldwide. While around half of T. vaginalis infections are asymptomatic, symptoms of the infection can range from vaginitis and frothy discharge, to male and female infertility, pre-terms births, increased incidences of malignant cervical cancers, and increased spread of HIV. T. vaginalis was recently classified as a neglected infection in the US, as very little is known about its modes of pathogenesis, how the immune system clears the parasite, or whether immunological memory is established following infection. Rising drug resistance and lack of a vaccine demand further research into the parasite- host interactions: specifically, what effective immunity to the parasite entails. It has long been known that immune- cells called neutrophils are crucial for immune- clearance of T. vaginalis, however it was only recently discovered that neutrophils use a previously unknown antimicrobial mechanism called trogocytosis (trogo= to nibble) to kill this relatively large, motile pathogen. Neutrophil trogocytosis of T. vaginalis was found to be a contact-dependent process, in which neutrophils surround the parasite, and internalize multiple fragments ( bites ) of T. vaginalis prior to parasite death. However, the molecules that mediate neutrophil-parasite cell- cell contact to initiate trogocytosis are unknown, as are the cellular mechanisms that neutrophils use to nibble and degrade parasite bites, causing death of the parasite. As human serum is required for neutrophil trogocytosis of T. vaginalis, we hypothesize that human serum factors crosslink parasite surface antigens to immune- receptors on neutrophils to establish cell-cell contact and initiate trogocytosis. We also hypothesize that neutrophil toxic granules containing membrane- degrading factors are mobilized to the neutrophil- parasite interface to mediate nibbling, and that lysosomal degradation of parasite bites is required for sustained nibbling to kill the parasite. We will test these hypotheses using a series of genetic loss- of- function experiments, using CRISPR-Cas9 to functionally delete candidate genes in a cell-line (HL-60s) that is a developmental precursor to neutrophils, and then differentiate the cells into neutrophil-like cells for functional tests. Our preliminary data show that HL-60s are a suitable and tractable model for studying trogocytic killing of T. vaginalis. We will also perform imaging experiments in the presence of lysosomal markers, and perform trogocytosis assays in the presence of lysosomal inhibitors. Altogether, these studies will outline the subcellular and molecular mechanisms that human- immune cells use to effectively clear T. vaginalis, information that will be invaluable in informing vaccine design. Furthermore, these studies will contribute foundational knowledge regarding a novel antimicrobial process.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2023	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	4	4/11/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $110,250 )
2023	2023	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	001	4	3/7/2023	NON-COMPETING CONTINUATION	$11,025
2023	2023	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	4	1/12/2023	NON-COMPETING CONTINUATION	$99,225
														Subtotal = $110,250

Issue Date FY: 2022 ( Subtotal = $110,250 )
2022	2022	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	001	3	6/20/2022	NON-COMPETING CONTINUATION	$11,025
2022	2022	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	3	1/21/2022	NON-COMPETING CONTINUATION	$99,225
														Subtotal = $110,250

Issue Date FY: 2021 ( Subtotal = $110,250 )
2021	2021	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	001	2	2/17/2021	NON-COMPETING CONTINUATION	$11,025
2021	2021	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	2	1/28/2021	NON-COMPETING CONTINUATION	$99,225
														Subtotal = $110,250

Issue Date FY: 2020 ( Subtotal = $110,250 )
2020	2020	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	1	2/6/2020	NEW	$110,250
														Subtotal = $110,250

Grand Total All Awards = $441,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Determining the subcellular and molecular players in neutrophil trogocytic killing of the sexually-transmitted parasite Trichomonas vaginalis

Award Number: SC3GM135046

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/10/2020

PERIOD OF PERFORMANCE END DATE: 01/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer